[HTML][HTML] Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination-a case …
E Ravlo, A Ianevski, E Starheim, W Wang, P Ji… - International Journal of …, 2023 - Elsevier
Vaccinated convalescents do not develop severe COVID-19 after infection with new SARS-
CoV-2 variants. We questioned how messenger RNA (mRNA) vaccination of convalescents …
CoV-2 variants. We questioned how messenger RNA (mRNA) vaccination of convalescents …
Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects
A Haveri, A Solastie, N Ekström… - European journal of …, 2022 - Wiley Online Library
The emergence of SARS‐CoV‐2 Omicron variant (B. 1.1. 529) with major spike protein
mutations has raised concern over potential neutralization escape and breakthrough …
mutations has raised concern over potential neutralization escape and breakthrough …
Analysis and comparison of SARS-CoV-2 variant antibodies and neutralizing activity for 6 months after a booster mRNA vaccine in a healthcare worker population.
P Horvath, R Nakajima, A Palma, A Hoang, E Razzak… - 2023 - escholarship.org
INTRODUCTION: In the context of recurrent surges of SARS-CoV-2 infections, a detailed
characterization of antibody persistence over a 6-month period following vaccine booster …
characterization of antibody persistence over a 6-month period following vaccine booster …
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
L Wang, MH Kainulainen, N Jiang, H Di… - Nature …, 2022 - nature.com
The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
resulted in the emergence of new variant lineages that have exacerbated the COVID-19 …
resulted in the emergence of new variant lineages that have exacerbated the COVID-19 …
mRNA COVID-19 vaccine booster fosters B-and T-cell responses in immunocompromised patients
E Azzolini, C Pozzi, L Germagnoli… - Life Science …, 2022 - life-science-alliance.org
SARS-CoV-2 vaccination has proven effective in inducing an immune response in healthy
individuals and is progressively us allowing to overcome the pandemic. Recent evidence …
individuals and is progressively us allowing to overcome the pandemic. Recent evidence …
[HTML][HTML] Analysis and comparison of SARS-CoV-2 variant antibodies and neutralizing activity for 6 months after a booster mRNA vaccine in a healthcare worker …
S Khan, S Hosseinian, R Assis, G Khalil, M Luu… - Research …, 2022 - ncbi.nlm.nih.gov
In the context of recurrent surges of SARS-CoV-2 infections, a detailed characterization of
antibody persistence over a 6-month period following vaccine booster dose is necessary to …
antibody persistence over a 6-month period following vaccine booster dose is necessary to …
Analysis and comparison of SARS-CoV-2 variant antibodies and neutralizing activity for 6 months after a booster mRNA vaccine in a healthcare worker population
S Hosseinian, R de Assis, G Khalil, MK Luu… - Frontiers in …, 2023 - frontiersin.org
Introduction In the context of recurrent surges of SARS-CoV-2 infections, a detailed
characterization of antibody persistence over a 6-month period following vaccine booster …
characterization of antibody persistence over a 6-month period following vaccine booster …
Durability of humoral and cell‐mediated immune response after SARS‐CoV‐2 mRNA vaccine administration
A Mihaylova, S Lesichkova, M Baleva… - Journal of Medical …, 2023 - Wiley Online Library
Vaccination against the SARS‐Cov‐2 virus is an effective way to protect against the disease
and the severe course of COVID‐19. Forty‐nine fully vaccinated with mRNA vaccines …
and the severe course of COVID‐19. Forty‐nine fully vaccinated with mRNA vaccines …
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
TM Narowski, K Raphel, LE Adams, J Huang, NA Vielot… - Cell reports, 2022 - cell.com
Understanding vaccine-mediated protection against severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) is critical to overcoming the global coronavirus disease 2019 …
coronavirus-2 (SARS-CoV-2) is critical to overcoming the global coronavirus disease 2019 …
[HTML][HTML] Neutralization of the emerging SARS-CoV-2 variant Lambda by antibodies elicited by inactivated virus and mRNA vaccines
M Acevedo, L Alonso-Palomares, MM de Oca… - 2021 - europepmc.org
Here, we used pseudotyped viruses to characterize the neutralization capacity of antibodies
elicited by the CoronaVac and BNT162b2 vaccines against the emerging variant of interest …
elicited by the CoronaVac and BNT162b2 vaccines against the emerging variant of interest …